Literature DB >> 14696025

Prolonged QTc intervals in medicated patients with schizophrenia.

Siow Ann Chong1, Alvin Lum, Hern Yee Goh, Yiong Huak Chan.   

Abstract

Psychotropic drugs have been associated with sudden deaths and the lengthening of corrected-QT interval (QTc) on the electrocardiogram which may be a precursor of life-threatening arrhythmias as reported with some of these drugs. The objectives of this study were to measure the frequency of QTc lengthening in patients with schizophrenia receiving psychotropic drugs, and to assess whether QTc lengthening was associated with certain psychotropic drugs and other risk factors. One hundred and sixty three patients with schizophrenia (104 males and 59 females) were included in the study. Clinical and demographic data were collected from the case records. One hundred healthy volunteers were recruited to establish values for upper limits of normal for measurement of QTc interval and dispersion. Eleven (6.7%) of the patients had a prolonged QTc interval. The significant predictors obtained from a logistic regression modelling were chlorpromazine, flupenthixol decanoate and fluphenazine decanoate. Caution should be exercised and monitoring with ECG should be considered in patients prescribed chlorpromazine and depot antipsychotic medications even at recommended doses. Copyright 2003 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14696025     DOI: 10.1002/hup.540

Source DB:  PubMed          Journal:  Hum Psychopharmacol        ISSN: 0885-6222            Impact factor:   1.672


  5 in total

Review 1.  QTc prolongation by psychotropic drugs and the risk of Torsade de Pointes.

Authors:  Katharina Wenzel-Seifert; Markus Wittmann; Ekkehard Haen
Journal:  Dtsch Arztebl Int       Date:  2011-10-14       Impact factor: 5.594

2.  Sex difference in QTc prolongation in chronic institutionalized patients with schizophrenia on long-term treatment with typical and atypical antipsychotics.

Authors:  Fu De Yang; Xiang Qun Wang; Xiu Ping Liu; Ke Xin Zhao; Wei Hong Fu; Xue Ru Hao; Xing Li Zhang; Guo Shu Huang; Sheng Cai Qu; Jing Shen Bai; Xu Feng Huang; Thomas R Kosten; Xiang Yang Zhang
Journal:  Psychopharmacology (Berl)       Date:  2011-02-09       Impact factor: 4.530

3.  Prevalence of ECG abnormalities and risk factors for QTc interval prolongation in hospitalized psychiatric patients.

Authors:  Nicolas Ansermot; Meredith Bochatay; Jürg Schläpfer; Mehdi Gholam; Ariane Gonthier; Philippe Conus; Chin B Eap
Journal:  Ther Adv Psychopharmacol       Date:  2019-12-12

4.  QT is longer in drug-free patients with schizophrenia compared with age-matched healthy subjects.

Authors:  Kumiko Fujii; Yuji Ozeki; Hiroaki Okayasu; Yumiko Takano; Takahiro Shinozaki; Hiroaki Hori; Masami Orui; Minoru Horie; Hiroshi Kunugi; Kazutaka Shimoda
Journal:  PLoS One       Date:  2014-06-02       Impact factor: 3.240

5.  The Contribution of National Spontaneous Reporting Systems to Detect Signals of Torsadogenicity: Issues Emerging from the ARITMO Project.

Authors:  Emanuel Raschi; Elisabetta Poluzzi; Francesco Salvo; Ariola Koci; Marc Suling; Stefania Antoniazzi; Luisella Perina; Lorna Hazell; Ugo Moretti; Miriam Sturkenboom; Edeltraut Garbe; Antoine Pariente; Fabrizio De Ponti
Journal:  Drug Saf       Date:  2016-01       Impact factor: 5.606

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.